Regulators Say Bayer Drug Unproven as Stroke Preventer

by Kathy Jones on  September 8, 2011 at 6:28 PM Drug News   - G J E 4
Xarelto, a Bayer-made drug approved in July for preventing blood clots, is so far unproven for a new proposed use as a stroke preventer, US regulators have said.
 Regulators Say Bayer Drug Unproven as Stroke Preventer
Regulators Say Bayer Drug Unproven as Stroke Preventer

"There is a lack of substantial evidence that rivaroxaban will have its desired effect when used as recommended in labeling," said documents released by the US Food and Drug Administration.

An advisory committee to the FDA would further discuss the latest findings on Thursday.

"This review posted today has to do with the application for the new use and at this point does not impact the already-approved use," said FDA spokeswoman Sandy Walsh.

Xarelto is currently on the market to reduce the risk of blood clots, deep vein thrombosis, and pulmonary embolism following knee or hip replacement surgery.

Bayer's stock plunged nearly 12 percent by midday in US trading.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like